The pruritus treatment developer, which counts Novo and Merck & Co as shareholders, has closed its initial public offering, its shares having almost doubled in price.

Ripple Foods, a developer of vegan substitutes for dairy products, increased its overall funding to $110m with a round featuring existing investor GV.

The immuno-oncology drug developer, which is backed by Celgene and GV, floated above its range and has since seen its share price rise 75%.

Corporate venturing units InnovAllianz and Via ID both invested in the France-based ride hailing service as it prepares to expand geographically.

The R/GA-backed payment processing and inventory management software has now raised $20m in each of its last two funding rounds.

The surplus food e-commerce platform has secured $12.6m in an Ikea-backed round that likely also featured Axel Johnson.

Oxford spinout Bodle Technologies has secured series A funding from investors including university venture fund Oxford Sciences Innovation.

The pharmaceutical development technology provider has received funding from investors including Google and series A backer Tencent.

The seed and fertliliser producer, which counts Monsanto as an investor, has set the range for an initial public offering that could net up to $142m.

The safe-driving app developer took its overall funding to almost $45m with a round featuring Alibaba Innovation Ventures and Nationwide.